CJ
JAZZ icon

Caitlin John’s Jazz Pharmaceuticals JAZZ Stock Holding History

Caitlin John’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$723 Hold
3
– – ﹤0.01% 913
2026
Q1 		$567 Hold
3
– – ﹤0.01% 846
2025
Q4 		$510 Hold
3
– – ﹤0.01% 852
2025
Q3 		$395 Buy
+3
New +$360 ﹤0.01% 832
2025
Q1 		– Sell
-3
Closed -$369 – 471
2024
Q4 		$369 Hold
3
– – ﹤0.01% 798
2024
Q3 		$383 Hold
3
– – ﹤0.01% 790
2024
Q2 		$320 Hold
3
– – ﹤0.01% 792
2024
Q1 		$361 Hold
3
– – ﹤0.01% 820
2023
Q4 		$369 Buy
+3
New +$374 ﹤0.01% 821

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Caitlin John's JAZZ Position: Q2 2026 in Review

Caitlin John held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 3 shares worth $723. The position accounts for ﹤0.01% of the portfolio, ranked #913.

Caitlin John first reported a position in JAZZ in Q4 2023 and has held it in 9 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Caitlin John held 3 shares of Jazz Pharmaceuticals worth $723 as of Q2 2026.
  • Caitlin John left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Caitlin John's portfolio in Q2 2026, its #913 holding.
  • Caitlin John first reported a position in Jazz Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.